National Asset Management Inc. lifted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 6.1% in the 3rd quarter, Holdings Channel.com reports. The firm owned 5,669 shares of the medical research company’s stock after purchasing an additional 326 shares during the period. National Asset Management Inc.’s holdings in Agilent Technologies were worth $568,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in the company. Courier Capital LLC purchased a new stake in shares of Agilent Technologies during the 3rd quarter worth $208,000. Quantitative Systematic Strategies LLC lifted its position in shares of Agilent Technologies by 49.9% during the 3rd quarter. Quantitative Systematic Strategies LLC now owns 24,426 shares of the medical research company’s stock worth $2,466,000 after purchasing an additional 8,136 shares during the last quarter. Kestra Private Wealth Services LLC purchased a new stake in shares of Agilent Technologies during the 3rd quarter worth $243,000. Livforsakringsbolaget Skandia Omsesidigt lifted its position in shares of Agilent Technologies by 141.3% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 7,855 shares of the medical research company’s stock worth $793,000 after purchasing an additional 4,600 shares during the last quarter. Finally, Commerce Bank lifted its position in shares of Agilent Technologies by 0.5% during the 3rd quarter. Commerce Bank now owns 112,694 shares of the medical research company’s stock worth $11,375,000 after purchasing an additional 541 shares during the last quarter.
Shares of Agilent Technologies stock opened at $110.89 on Friday. Agilent Technologies, Inc. has a 52-week low of $61.13 and a 52-week high of $117.50. The company has a quick ratio of 1.90, a current ratio of 2.47 and a debt-to-equity ratio of 0.46. The company’s 50-day simple moving average is $106.20 and its 200-day simple moving average is $95.27. The firm has a market cap of $34.19 billion, a price-to-earnings ratio of 50.18, a price-to-earnings-growth ratio of 3.04 and a beta of 1.02.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 27th. Stockholders of record on Tuesday, January 5th will be paid a dividend of $0.194 per share. This represents a $0.78 dividend on an annualized basis and a dividend yield of 0.70%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.18. The ex-dividend date of this dividend is Monday, January 4th. Agilent Technologies’s payout ratio is 23.15%.
In other Agilent Technologies news, SVP Michael Tang sold 3,333 shares of the company’s stock in a transaction dated Friday, October 30th. The shares were sold at an average price of $101.77, for a total transaction of $339,199.41. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Rodney Gonsalves sold 6,191 shares of the company’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $98.17, for a total transaction of $607,770.47. Following the transaction, the vice president now owns 48,334 shares in the company, valued at $4,744,948.78. The disclosure for this sale can be found here. Insiders have sold 19,342 shares of company stock worth $1,968,588 over the last 90 days.
A has been the subject of several recent analyst reports. Cleveland Research raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating in a research report on Tuesday. Needham & Company LLC reissued a “hold” rating on shares of Agilent Technologies in a research report on Wednesday, August 19th. HSBC raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $30.70 price target for the company in a research report on Monday, November 9th. Bank of America boosted their price target on shares of Agilent Technologies from $99.00 to $103.00 and gave the company a “neutral” rating in a research report on Wednesday, August 19th. Finally, Jefferies Financial Group boosted their price target on shares of Agilent Technologies from $95.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, August 19th. Fourteen equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $86.51.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Recommended Story: Cryptocurrencies
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.